-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel. Bioinformatics Resource Centers for Infectious Diseases.
Date: April 22, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Start Printed Page 12370Drive, MSC 7616, Bethesda, MD 20892, 301-402-3938. lr228v@nih.gov.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel. Bioinformatics Resource Centers for Infectious Diseases.
Date: April 23, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892. 301-402-3938. lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Start SignatureEnd Signature End PreambleDated: March 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-6477 Filed 3-23-09; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Effective Date:
- 4/22/2009
- Published:
- 03/24/2009
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- E9-6477
- Dates:
- April 22, 2009.
- Pages:
- 12369-12370 (2 pages)
- PDF File:
- e9-6477.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute